» Articles » PMID: 33725342

New Therapeutic Approaches and Biomarkers for Increased Healthspan

Overview
Date 2021 Mar 16
PMID 33725342
Authors
Affiliations
Soon will be listed here.
Abstract

Healthcare costs have increased in developing countries over the last few decades, mostly due to the escalation in average life expectancy and the concomitant increase in age-related disorders. To address this issue, widespread research is now being undertaken across the globe with the aim of finding a way of increasing healthy aging. A number of potential interventions have already shown promise, including lifestyle changes and the use of natural products or pharmaceuticals that may delay the onset of diseases associated with the aging process. In parallel, a number of potential biomarkers have already been identified that can be used for assessing risk of developing age-associated disorders and for monitoring response to therapeutic interventions. This review describes the most recent advances towards the goal of achieving healthier aging with fewer disabilities that may lead to enhanced quality of life and reduced healthcare costs around the world.

References
1.
Schork N, Raghavachari N . Report: NIA workshop on translating genetic variants associated with longevity into drug targets. Geroscience. 2018; 40(5-6):523-538. PMC: 6294726. DOI: 10.1007/s11357-018-0046-7. View

2.
Guest P . Metabolic Biomarkers in Aging and Anti-Aging Research. Adv Exp Med Biol. 2019; 1178:247-264. DOI: 10.1007/978-3-030-25650-0_13. View

3.
Guest P . Of Mice, Whales, Jellyfish and Men: In Pursuit of Increased Longevity. Adv Exp Med Biol. 2019; 1178:1-24. DOI: 10.1007/978-3-030-25650-0_1. View

4.
Hazzard W . Why do women live longer than men? Biologic differences that influence longevity. Postgrad Med. 1989; 85(5):271-8, 281-3. DOI: 10.1080/00325481.1989.11700672. View

5.
Austad S, Bartke A . Sex Differences in Longevity and in Responses to Anti-Aging Interventions: A Mini-Review. Gerontology. 2015; 62(1):40-6. DOI: 10.1159/000381472. View